Merck Serono Chooses Genedata Biologics to Streamline Antibody Discovery Processes

News   Jul 23, 2015

 
Merck Serono Chooses Genedata Biologics to Streamline Antibody Discovery Processes
 
 
 

RELATED ARTICLES

Broadly Acting Antibodies Found in Blood of Ebola Survivors

News

Scientists have discovered a set of powerful, broadly neutralizing antibodies in the blood of Ebola survivors. In animal studies, two of these antibodies provided substantial protection against disease caused by the three species known to cause fatal human illness.

READ MORE

Getting to Know the Microbes that Drive Climate Change

News

A new understanding of the microbes and viruses in the thawing permafrost in Sweden may help scientists better predict the pace of climate change.

READ MORE

How Many People Die From TB Every Year?

News

Discrepancies between the estimates for global tuberculosis deaths is due to different methodologies and data sources used by each institution. The results highlight the need to improve the modeling approaches in these countries in order to understand the true burden of the disease and design adequate health policies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy